Kenneth L. Hauser
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Synthesis and Reactions of Organic Compounds, Inflammatory mediators and NSAID effects, Estrogen and related hormone effects, Chemical Synthesis and Analysis, Cholinesterase and Neurodegenerative Diseases
Most-Cited Works
- → A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine(1974)475 cited
- → Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[b]thiophene: A Novel, Highly Potent, Selective Estrogen Receptor Modulator(1997)176 cited
- → Dibasic Benzo[b]thiophene Derivatives as a Novel Class of Active Site-Directed Thrombin Inhibitors. 1. Determination of the Serine Protease Selectivity, Structure−Activity Relationships, and Binding Orientation(1997)54 cited
- → Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146(1999)28 cited
- → Structural Evolution and Pharmacology of a Novel Series of Triacid Angiotensin II Receptor Antagonists(1994)24 cited
- → Approaches to the chemical synthesis of the prostaglandins(1968)14 cited
- → Chiral recognition of the angiotensin II (AT1) receptor by a highly potent phenoxyproline octanoamide(1994)10 cited
- → Pharmacological Profiles of Four New Tetracyclic Dopamine Antagonists, Maroxepine, Citatepine, Eresepine, and Cipazoxapine(1986)10 cited
- → Synthesis and pharmacological evaluation of a novel series of 5-aryl benzimidazole angiotensin II receptor antagonists(1995)5 cited
- → Molecular Modeling and Quantitative Structure—Activity Relationship Studies in Pursuit of Highly Potent Substituted Octanoamide Angiotensin II Receptor Antagonists(1995)4 cited